Nevertheless, although it is clear that SIRT3 has great potential for treating bone-related diseases, such as OP and IDD, further validation through additional animal studies and clinical trials is needed to provide new drug targets (Figure 5). The gene discussed is SIRT3; the disease is intervertebral disk degenerative disorder.